Le Parisien.fr Reports:
The High Authority for Health, based on the new opinion of the European Medicines Agency and on the Epi-Phare report confirming the risk of myocarditis and pericarditis, recommends dispensing with the Moderna vaccine in young people.
Three weeks break, and let’s go? Probably not for everyone. The High Authority for Health (HAS) recommends this Monday the resumption of booster vaccinations with Moderna, but it advises against it in any case for those under 30 years old. The American biotech product was suspended on October 15 in France for booster injections, following the alert issued by several Scandinavian countries concerning a possible increased risk of myocarditis and pericarditis in the youngest .
It is precisely for this reason, supported by a French study published on Monday, that the HAS now completely advises Moderna among those under 30. The risk of myocarditis and pericarditis appears particularly high after the second dose in young men aged 12 to 29, with one case hospitalized for 7600 injections within seven days of the injection.